GeneDx Holdings Corp.
WGS- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001818331
In the last 90 days, GeneDx Holdings Corp. insiders filed 0 open-market purchases and 5 sales; 223 institutions reported holding it in 13F filings for Q2 2026, worth $2.17B in total; ARK Invest is the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding GeneDx Holdings Corp. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 53 | 3 | 48 | −2 |
| Shares | 13.9M | 312.9K | 12.4M | −1.19M (−8.7%) |
| Value | $50.8M | $1.14M | $34.2M | −$15.4M (−31.1%) |
3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held GeneDx Holdings Corp. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 313,659 | $862.6K | 0.00% |
| Millennium Management LLC | 132,358 | $364.0K | 0.00% |
| Decheng Capital LLC | 103,604 | $284.9K | 0.08% |
| Acadian Asset Management LLC | 61,548 | $168.0K | 0.00% |
| Pathstone Holdings, LLC | 57,439 | $158.0K | 0.00% |
| Two Sigma Investments, LP | 14,464 | $39.8K | 0.00% |
| Prudential Financial Inc | 13,200 | $36.3K | 0.00% |
| Simplex Trading, LLC | 484 | $1.00K | 0.00% |
| Capital Advisors, Ltd. LLC | 463 | $1.00K | 0.00% |
| Deutsche Bank AG | 1 | $3 | 0.00% |
Sold out (12)
Institutions that held GeneDx Holdings Corp. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Marshall Wace, LLP | 699,528 | $2.55M |
| HighTower Advisors, LLC | 237,948 | $865.0K |
| Alyeska Investment Group, L.P. | 98,553 | $358.7K |
| Trexquant Investment LP | 45,532 | $165.7K |
| Squarepoint Ops LLC | 38,403 | $139.8K |
| Winton Group Ltd | 20,145 | $73.3K |
| Prelude Capital Management, LLC | 18,591 | $67.7K |
| Citadel Advisors LLC | 7,803 | $28.4K |
| Qube Research & Technologies Ltd | 1,939 | $7.06K |
| UBS Group AG | 192 | $699 |
| Stone House Investment Management, LLC | 31 | $113 |
| Cornerstone Planning Group LLC | 16 | $58 |
Not filed for Q4 2023 yet (3)
Institutions that held GeneDx Holdings Corp. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Trellus Management Company, LLC | 155,012 | $564.2K |
| Decheng Capital Management III (Cayman), LLC | 103,604 | $377.1K |
| Pathstone Family Office, LLC | 54,327 | $197.8K |